GL1X · GenesisL1 explorer

Research workbench

MERS S ectodomain trimer in complex with neutralizing antibody 0722 (state 1)

Analyse MERS S ectodomain trimer in complex with neutralizing antibody 0722 (state 1) in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7V5K
Type
protein
Length
4,725 residues
Chains
9
Method
electron microscopy
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.8
Source
Homo sapiens; Human betacoronavirus 2c EMC/2012
Molecule
Spike glycoprotein; 0722 L; 0722 H
UniProt
K0BRG7
Pockets
20 · best druggability 0.83

Structure

electron microscopy · resolution 2.8 · 3 distinct chains · 17% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, CSpike glycoproteinprotein114122% helix, 25% strandK0BRG7
D, F, H0722 Lprotein2125% helix, 49% strand—
E, G, I0722 Hprotein2224% helix, 48% strand—

Pockets

20 pockets found on a 1 Å grid, 20 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16760.830.8877empty
211150.820.83141empty
36850.820.8669empty
48320.820.8486empty
57900.800.8372empty

Interfaces

12 interfaces between chains.

  • B–C · 4874 Ų buried · 48 hydrogen bonds · protein-protein
  • A–B · 4844 Ų buried · 63 hydrogen bonds · protein-protein
  • A–C · 3805 Ų buried · 36 hydrogen bonds · protein-protein
  • H–I · 1552 Ų buried · 11 hydrogen bonds · protein-protein
  • D–E · 1504 Ų buried · 5 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 47 disulfide (disulfide).

Compared structures

  • 7V5K · MERS S ectodomain trimer in complex with neutralizing antibody 0722 (state 1) · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.